Jonathan Marshall
Impact in
-
- Inhalation and Respiratory Drug Delivery
- Chronic Obstructive Pulmonary Disease (COPD) Research
- Family Practice top 10%
- Medication Adherence and Compliance
Papers in
-
- Chronic Obstructive Pulmonary Disease (COPD) Research 13
- Inhalation and Respiratory Drug Delivery 8
-
- Asthma and respiratory diseases 1
- Co-authors
- Emily Farrington (1 shared paper)Federico Lavorini (1 shared paper)Louise Heron (2 shared papers)Richard P.N. Dekhuijzen (1 shared paper)W. Dunlop (2 shared papers)Manfréd M. Fischer (2 shared papers)Jan De Backer (2 shared papers)Hana Müllerová (6 shared papers)
- Journals
- Respiratory Research (4 papers)Therapeutic Advances in Respiratory Disease (2 papers)BMJ Open (2 papers)International Journal of COPD (2 papers)Current Medical Research and Opinion (2 papers)
- Partner nations
- United KingdomUnited StatesSweden
In The Last Decade
Jonathan Marshall
19 papers receiving 496 citations
Jonathan Marshall's Hit Papers
Peers
Comparison fields: 5 of 31
- Pulmonary and Respiratory Medicine 426
- Family Practice 17
- Physiology 102
- Pharmacology 35
- Drug Discovery 1
Countries citing papers authored by Jonathan Marshall
This map shows the geographic impact of Jonathan Marshall's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jonathan Marshall with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jonathan Marshall more than expected).
Fields of papers citing papers by Jonathan Marshall
This network shows the impact of papers produced by Jonathan Marshall. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jonathan Marshall. The network helps show where Jonathan Marshall may publish in the future.
Co-authors
The 25 scholars most cited alongside Jonathan Marshall, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 21 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Critical inhaler errors in asthma and COPD: a systematic review of impact on health outcomes Hit paper breakdown → | 2018 | 292 |
| 2 | 2013 | 58 | |
| 3 | 2022 | 47 | |
| 4 | 2018 | 24 | |
| 5 | 2023 | 20 | |
| 6 | 2017 | 19 | |
| 7 | 2023 | 18 | |
| 8 | 2015 | 12 | |
| 9 | 2023 | 9 | |
| 10 | 2019 | 7 | |
| 11 | 2022 | 4 | |
| 12 | 2022 | 4 | |
| 13 | 2025 | 4 | |
| 14 | Comparison of the fine particle fraction of fluticasone propionate/formoterol fumarate combination with other combination products | 2012 | 3 |
| 15 | 2024 | 3 | |
| 16 | 2014 | 1 | |
| 17 | 2024 | 1 | |
| 18 | 2025 | 1 | |
| 19 | 2025 | 1 | |
| 20 | 2025 | 0 |
About Jonathan Marshall
Jonathan Marshall is a scholar working on Pulmonary and Respiratory Medicine, Physiology, Nuclear Energy and Engineering, Waste Management and Disposal and Infectious Diseases, having authored 21 papers that have together received 528 indexed citations. Recurring topics across this work include Chronic Obstructive Pulmonary Disease (COPD) Research (13 papers), Inhalation and Respiratory Drug Delivery (8 papers) and Asthma and respiratory diseases (1 paper). The work is most often cited by research in Pulmonary and Respiratory Medicine (426 citations), Family Practice (17 citations), Physiology (102 citations), Pharmacology (35 citations) and Drug Discovery (1 citation). Jonathan Marshall has collaborated with scholars based in United Kingdom, United States and Sweden. Frequent co-authors include Emily Farrington, Federico Lavorini, Louise Heron, Richard P.N. Dekhuijzen, W. Dunlop, Manfréd M. Fischer, Jan De Backer, Hana Müllerová, Clémentine Nordon and Enrico De Nigris. Their work appears in journals such as Respiratory Research, Therapeutic Advances in Respiratory Disease, BMJ Open, International Journal of COPD and Current Medical Research and Opinion.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.